What is Andres Tobon's NPI number?

Andres Tobon's National Provider Identifier (NPI) is 1780799460, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.

What is Andres Tobon's specialty?

Andres Tobon is listed in the NPPES registry with a primary specialty of Dermatology Physician (Allopathic & Osteopathic Physicians).

Where is Andres Tobon located?

Andres Tobon's practice location on file with NPPES is 405 W. Bloomingdale Ave, Brandon, FL 33511-7401.

What is Andres Tobon's phone number?

The practice phone number listed in the NPPES registry for Andres Tobon is (813) 662-3376.

Does Andres Tobon accept Medicare?

Andres Tobon is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.

Is Andres Tobon's NPI active?

Yes — Andres Tobon's NPI (1780799460) is active in the NPPES registry as of the last update on 2008-03-25.

IndividualActiveAccepts Medicare

Andres Tobon, DO

NPI 1780799460 · Dermatology Physician · Brandon, FL

Andres Tobon, DO is a Dermatology Physician provider in Brandon, FL (NPI 1780799460).

Provider details

NPI number: 1780799460
Entity type: Individual
Primary specialty: Dermatology PhysicianAllopathic & Osteopathic Physicians
Credential: DO
Sex: Male
Sole proprietor: No
License: OS 7868 (FL)

Practice location

405 W. Bloomingdale Ave

Brandon, FL 33511-7401

Phone: (813) 662-3376

Fax: (813) 662-3009

Street-level locationGet directions

More FL providers

Mailing address

405 W Bloomingdale Ave

Brandon, FL 33511-7401

Specialties & taxonomies

Dermatology PhysicianPrimary207N00000XLicense OS 7868 (FL)
Allopathic & Osteopathic Physicians

Enrolled with Medicare as Practitioner - Dermatology · source: CMS PECOS Public Provider Enrollment (2026.04.01)

Profile Score

Detailed profile(82/100 index)

A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.

Registry tenure25% of score
20 yrs in NPPES registry
Profile completeness25% of score
100% of core fields populated
Practice footprint15% of score
1 documented practice location
Medicare service volume (vs. specialty peers)25% of score
3,901 Medicare services, 2024 (ranked within specialty)
Open Payments transparency10% of score
Has Open Payments disclosures (2024)

Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our methodology.

What this provider does (Medicare)

Based on Medicare fee-for-service claims, 2024; not all care is captured.

Service (HCPCS)	Medicare services	Typical Medicare-allowed (2024)
Destruction of Precancer Skin Growth, 2-14 Growths17003	984	$6
Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213	651	$90
Biopsy of Related Skin Growth, First Growth11102	539	$96
Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214	532	$127
Biopsy of Related Skin Growth, Each Additional Growth11103	496	$49
Destruction of Precancer Skin Growth, 1 Growth

What this provider prescribes (Medicare Part D)

Top drugs by Medicare Part D claim volume, 2024 · 26 distinct drugs on file.

Drug	Part D claims (2024)	Beneficiaries
Ketoconazole	308	174
Triamcinolone Acetonide	264	194
Doxycycline Hyclate	164	103
Imiquimod	148	110
Mupirocin	125	90
Clobetasol Propionate	114	58
Valacyclovir Hclbrand: Valacyclovir	72	23
Gabapentin	70

Transparency — industry payments

Based on CMS Open Payments, 2024; not all care is captured.

$973 across 26 records (Open Payments 2024)

Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.

Enumerated: 2006-08-20
Last updated: 2008-03-25

Frequently asked questions

What is Andres Tobon's NPI number?: Andres Tobon's National Provider Identifier (NPI) is 1780799460, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.
What is Andres Tobon's specialty?: Andres Tobon is listed in the NPPES registry with a primary specialty of Dermatology Physician (Allopathic & Osteopathic Physicians).
Where is Andres Tobon located?: Andres Tobon's practice location on file with NPPES is 405 W. Bloomingdale Ave, Brandon, FL 33511-7401.
What is Andres Tobon's phone number?: The practice phone number listed in the NPPES registry for Andres Tobon is (813) 662-3376.
Does Andres Tobon accept Medicare?: Andres Tobon is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.
Is Andres Tobon's NPI active?: Yes — Andres Tobon's NPI (1780799460) is active in the NPPES registry as of the last update on 2008-03-25.

Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.

What this provider does (Medicare)

Based on Medicare fee-for-service claims, 2024; not all care is captured.

Service (HCPCS)	Medicare services	Typical Medicare-allowed (2024)
Destruction of Precancer Skin Growth, 2-14 Growths17003	984	$6
Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213	651	$90
Biopsy of Related Skin Growth, First Growth11102	539	$96
Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214	532	$127
Biopsy of Related Skin Growth, Each Additional Growth11103	496	$49
Destruction of Precancer Skin Growth, 1 Growth

Drug

Part D claims (2024)

Beneficiaries

Ketoconazole

308

174

Triamcinolone Acetonide

264

194

Doxycycline Hyclate

164

103

Imiquimod

148

110

Mupirocin

125

Clobetasol Propionate

114

Valacyclovir Hclbrand: Valacyclovir

Gabapentin

Transparency — industry payments

Based on CMS Open Payments, 2024; not all care is captured.

$973 across 26 records (Open Payments 2024)

Provider details

Practice location

Mailing address

Specialties & taxonomies

Profile Score

What this provider does (Medicare)

What this provider prescribes (Medicare Part D)

Transparency — industry payments

Registry dates

Frequently asked questions

Specialties & taxonomies

Frequently asked questions

Profile Score

What this provider does (Medicare)

What this provider prescribes (Medicare Part D)

Transparency — industry payments